RALEIGH, N.C. – Attorney General Josh Stein filed a friend-of-the-court brief in the U.S. Supreme Court to protect access to medication abortion nationwide.
Attorney General Stein and an additonal 24 attorneys general from other states filed the brief in support of the U.S. Food and Drug Administration’s (FDA) and Danco Laboratories LLC’s efforts to reverse a U.S. Court of Appeals for the Fifth Circuit ruling that reinstated certain medically unnecessary restrictions on the medication abortion drug mifepristone.
These restrictions on mifepristone could have dangerous consequences for women’s reproductive health care, particularly for underserved communities.
“No woman should ever have to worry about whether she can get the medication she needs,” said Attorney General Josh Stein. “I will continue to do everything in my power to stand up for women’s reproductive freedoms.”
In the brief, Attorney General Stein notes that if the Fifth Circuit’s decision is permitted to take effect, it could disrupt access to an effective method of abortion, harming countless women in need of medical care or pregnancy loss management. The lower court decision could also lead many people to undergo procedural abortions; create widespread confusion among providers, distributors, and pharmacies; and drive up risks, costs, and delays for reproductive health care more broadly.
Finally, overruling the FDA’s regulations would radically destabilize the approval process for a wide range of drugs, stifling scientific innovation and imperiling the development and availability of thousands of drugs nationwide.
Attorney General Stein is joined in filing this brief by the Attorneys General of Arizona, California, Colorado, Connecticut, Delaware, Hawai‘i, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, New York, Oregon, Pennsylvania, Rhode Island, Vermont, Washington, Wisconsin, and the District of Columbia.
